AtriCure, Inc. (ATRC) Reports Q4 Loss of $0.13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Nasdaq ticks up as tech stocks steady; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $59.10 -0.34%
Revenue Growth %: +12.5%
Financial Fact:
Selling, general and administrative expenses: 25.49M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Revenue Growth %: +12.5%
Financial Fact:
Selling, general and administrative expenses: 25.49M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
AtriCure, Inc. (NASDAQ: ATRC) reported Q4 EPS of ($0.13), $0.05 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $16.8 million versus the consensus estimate of $17.16 million.
For earnings history and earnings-related data on AtriCure, Inc. (ATRC) click here.
For earnings history and earnings-related data on AtriCure, Inc. (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AI-powered cyber threats light a fire under cybersecurity stocks
- Venture Global rises after QatarEnergy supply talks reported
- Wells Fargo Names Top Pick Ahead of Q3 Earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
